151 - 175 of 274 Items

Review paper2023, jun 30

The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes

Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Krzysztof Irlik, Oliwia Janota, Hanna Kwiendacz, Paulina Szromek-Białek, Mirosław Maziarz, Tomasz Stompór, Janusz Gumprecht, Gregory Y. H. Lip

Vol 74, No 4 (2023)

Review paper

Pubmed: 37431873
Endokrynol Pol 2023;74(4):349-362.
Review paper2024, jun 26

Iron and ferritin deficiency in women with hypothyroidism and chronic lymphocytic thyroiditis — systematic review

Marcin Gierach, Monika Rudewicz, Roman Junik

Vol 75, No 3 (2024)

Review paper

Pubmed: 38923898
Endokrynol Pol 2024;75(3):253-261.
Original paper2023, jul 18

Evaluation of pulmonary side effects in prolactinoma patients treated with cabergoline

Ozlem Soyluk, Zuleyha Bingol, Sema Ciftci, Neslihan Kurtulmus, Seher Tanrikulu, Sema Yarman

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577991
Endokrynol Pol 2023;74(4):380-384.
Original paper2022, jul 18

Association of antithyroid peroxidase antibodies with cardiac function in euthyroid women with type 1 diabetes mellitus — assessment with two-dimensional speckle‑tracking echocardiography

Magdalena Maria Łukawska-Tatarczuk, Agnieszka Pawlak, Jakub Zieliński, Edward Franek, Leszek Czupryniak, Beata Mrozikiewicz-Rakowska

Vol 73, No 5 (2022)

Original paper

Pubmed: 35971937
Endokrynol Pol 2022;73(5):812-822.
Review paper2023, oct 23

Secondary hyperparathyroidism in chronic kidney disease: pathomechanism and current treatment possibilities

Małgorzata Rodzoń-Norwicz, Sebastian Norwicz, Magdalena Sowa-Kućma, Agnieszka Gala-Błądzińska

Vol 74, No 5 (2023)

Review paper

Pubmed: 37902013
Endokrynol Pol 2023;74(5):490-498.
Review paper2023, oct 9

Adipose tissue as a cause of endocrine dysfunction

Alina Ewa Kuryłowicz

Vol 74, No 5 (2023)

Review paper

Pubmed: 37902012
Endokrynol Pol 2023;74(5):468-479.
Original paper2023, jul 27

A comparison of the 2 thermal ablation procedures for the management of benign thyroid nodules

Süleyman Sönmez, Elif Önder, Mehtap Navdar Başaran, Hatice Çalışkan, Yıldıray Topçu, Sevcan Genç, Hande Peynirci

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577995
Endokrynol Pol 2023;74(4):392-397.
Original paper2023, jul 11

Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas

Marta Opalińska, Aleksandra Gilis-Januszewska, Karolina Morawiec-Sławek, Anna Kurzyńska, Anna Sowa-Staszczak, Anna Bogusławska, Ewelina Rzepka, Alicja Hubalewska-Dydejczyk

Vol 74, No 4 (2023)

Original paper

Pubmed: 37431872
Endokrynol Pol 2023;74(4):363-371.
Original paper2023, aug 8

Ultrasound characteristics of the cervical vagus nerve in patients with type 2 diabetes and diabetic peripheral neuropathy

Fan Xiong, Qian Wang, Yun Hu, Xiao Jiang, Lin Liu, Yumeng Han, Qing Jiang, Shiqin Yuan, Lan Xu

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577998
Endokrynol Pol 2023;74(4):421-429.
Review paper2024, mar 13

Modifiable risk factors for thyroid cancer: lifestyle and residence environment

Yi Shen, Xian Wang, Lu Wang, Dandan Xiong, Cailian Wu, Liting Cen, Lianguang Xie, Xiangzhi Li

Vol 75, No 2 (2024)

Review paper

Pubmed: 38497372
Endokrynol Pol 2024;75(2):119-129.
Review paper2023, nov 9

Thyroid disease and autoimmunity in obese patients: a narrative review

Francesca Bambini, Elisa Gatta, Rossella D'Alessio, Francesco Dondi, Giusto Pignata, Ilenia Pirola, Francesco Bertagna, Carlo Cappelli

Vol 74, No 6 (2023)

Review paper

Pubmed: 37994585
Endokrynol Pol 2023;74(6):576-590.
Letter to the Editor2023, jul 27
Original paper2023, jun 20

Association between TSH suppression therapy and type 2 deiodinase gene polymorphism in differentiated thyroid carcinoma

Xiaoke Zheng, Lichang Zhong, Tianjiao Zhou, Feng Zhao, Bin Chen

Vol 74, No 4 (2023)

Original paper

Pubmed: 37431871
Endokrynol Pol 2023;74(4):408-413.
Clinical vignette2022, oct 13

Pulmonary embolism as the first manifestation of Cushing syndrome in a young woman

Mari Minasyan, Agata Bryk-Wiązania, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska

Vol 73, No 6 (2022)

Clinical vignette

Pubmed: 36621924
Endokrynol Pol 2022;73(6):990-991.
Original paper2023, aug 17

Choroidal vascular changes in non-alcoholic fatty liver disease

Enver Avcı, Ali Kucukoduk

Vol 74, No 4 (2023)

Original paper

Pubmed: 37823522
Endokrynol Pol 2023;74(4):430-436.
Review paper2024, mar 19

Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence of glioblastoma multiforme (GBM)?

Agata Czarnywojtek, Paweł Gut, Kamil Dyrka, Jerzy Sowiński, Nadia Sawicka-Gutaj, Katarzyna Katulska, Piotr Stajgis, Mateusz Wykrętowicz, Jakub Moskal, Jeremi Kościński, Krzysztof Pietrończyk, Patryk Graczyk, Maciej Robert Krawczyński, Ewa Florek, Ewelina Szczepanek-Parulska, Marek Ruchała, Alfio Ferlito

Vol 75, No 2 (2024)

Review paper

Pubmed: 38646982
Endokrynol Pol 2024;75(2):130-139.
Original paper2023, jul 21

Hyperandrogenism-related metabolic changes in drug-naïve transmen compared to cisgender women: a case-controlled study

Pınar Erel, Onur Elbasan, Neşe Yorguner, Eren İmre, Özlem Üstay

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577993
Endokrynol Pol 2023;74(4):398-403.
Original paper2023, jul 21

The value of [18F]FDG PET/CT in avoiding overtreatment of 131l avidity pulmonary metastasis of differentiated thyroid cancer

Zhongyun Xu, Chao Li, Fang Feng, Shuqi Wu, Hui Wang, Hongliang Fu

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577994
Endokrynol Pol 2023;74(4):385-391.
Clinical vignette2023, jul 18

Lethargic patient with hepatocirrhosis — more than meets the eye

Mateusz Maligłówka, Aleksandra Sojka, Anna Bartecka, Łukasz Bułdak, Bogusław Okopien

Vol 74, No 4 (2023)

Clinical vignette

Pubmed: 37578000
Endokrynol Pol 2023;74(4):443-444.
Original paper2023, jul 27

Clinical value of miR-23a-3p expression in early diagnosis of diabetic kidney disease

Xiaomei Meng, Xiao Yu, Peipei Lei

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577996
Endokrynol Pol 2023;74(4):414-420.
Original paper2023, jul 27

Previous, simultaneous, or subsequent occurrence of malignant tumours in patients with primary hyperparathyroidism: a closer look at the single-tertiary-centre cases

Havva Sezer, Hande Bulut Canbaz, Serdar Tezelman, Tarık Terzioğlu, Eda Nur Çilingiroğlu, Bülent Çolakoğlu, Dilek Yazıcı, Oğuzhan Deyneli, Mehmet Onur Demirkol, Adnan Batman, Seçil Özışık, Yersu Yapran, Faruk Alagöl

Vol 74, No 4 (2023)

Original paper

Pubmed: 37577997
Endokrynol Pol 2023;74(4):372-379.
Clinical vignette2022, oct 31

Pituitary stalk metastasis of a neuroendocrine tumour of unknown origin

Łukasz Kluczyński, Karolina Morawiec-Sławek, Jacek Pantofliński, Marta Opalińska, Anna Sowa-Staszczak, Anna Grochowska, Aleksandra Gilis-Januszewska, Alicja Hubalewska-Dydejczyk

Vol 73, No 6 (2022)

Clinical vignette

Pubmed: 36519655
Endokrynol Pol 2022;73(6):992-993.
Review paper2024, sep 27

Polycystic ovary syndrome and type 1 diabetes — the current state of knowledge

Edyta Cichocka, Anna Maj-Podsiadło, Janusz Gumprecht

Vol 75, No 5 (2024)

Review paper

Pubmed: 39376174
Endokrynol Pol 2024;75(5):479-485.
Clinical vignette2023, jun 26

Diagnostic and therapeutic difficulties in a patient with corticotropic pituitary macroadenoma

Grzegorz Erbert, Elżbieta Łomna-Bogdanov, Marek Bolanowski

Vol 74, No 4 (2023)

Clinical vignette

Pubmed: 37431874
Endokrynol Pol 2023;74(4):437-438.
Review paper2023, nov 20

Thyroid nodule core needle biopsy — current approach

Emrah Karatay, Mirkhalig Javadov, Hatice Kaya

Vol 74, No 6 (2023)

Review paper

Pubmed: 37994586
Endokrynol Pol 2023;74(6):591-600.